CRISPR
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CRSP Key Statistics
Stock Snapshot
The current CRISPR(CRSP) stock price is $41.00, with a market capitalization of 3.89B. The stock trades at a price-to-earnings (P/E) ratio of -8.46.
During the trading session on 2026-11-18, CRISPR(CRSP) shares reached a daily high of $41.00 and a low of $40.30. At a current price of $41.00, the stock is +1.7% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 10.91K, compared to an average daily volume of 2.34M.
The stock's 52-week range extends from a low of $39.80 to a high of $63.45.
The stock's 52-week range extends from a low of $39.80 to a high of $63.45.
CRSP News
...
CRISPR Therapeutics AG (CRSP Quick QuoteCRSP - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want t...
Crispr Therapeutics (CRSP) announced an update on their ongoing clinical study. Study Overview: Crispr Therapeutics is testing CTX460 in adults with emphysema...
Analyst ratings
57%
of 23 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.